My Cart [ 0 ]
New Products
New Services
News
Promotions
Home > Search Results
    104 products and services containing "mapk"
    Please click mapk to try advanced search.
  • PA007513.m2a: In Vivo Grade Recombinant Anti-mouse VEGF Monoclonal Antibody (Clone: B20-4.1.1.1), Mouse IgG2a Kappa

    The in vivo grade recombinant anti-mouse VEGF mouse IgG2a kappa monoclonal antibody was produced in mammalian cells. 
    Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: B20-4.1.1.1) specifically binds to mouse VEGF.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse VEGF protein.

     

  • PA007490.m2a: Recombinant Anti-mouse CD28 Monoclonal Antibody (Clone: PV-1), Mouse IgG2a Kappa

    Recombinant Mouse IgG2a Monoclonal Antibody.
    Conjugation: Non-conjugated.
    Specificity/Sensitivity: The recombinant PV-1 antibody specifically binds to mouse CD28.
    Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F).

     

    PA007490.h1Fs: Recombinant Anti-mouse CD28 Monoclonal Antibody (Clone: PV-1), Human IgG1 Fc Silent Kappa

    Recombinant human IgG1 Monoclonal Antibody with Fc silent mutation.
    Conjugation: Non-conjugated.
    Specificity/Sensitivity: The recombinant PV-1 antibody specifically binds to mouse CD28.
    Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F).

     

    PA007720.h1Fs-b: Biotinylated Recombinant Anti-mouse CD28 Monoclonal Antibody (Clone: PV-1), Human IgG1 Fc Silent Kappa

    Recombinant human IgG1 monoclonal antibody with site-directed biotinylation through the Avi tag at the C-terminus of the antibody heavy chain.
    Conjugation: Biotin-conjugated.
    Specificity/Sensitivity: The site-directed biotinylated recombinant PV-1 antibody specifically binds to mouse CD28.
    Applications: Flow cytometry (FC) with various dye conjugation through streptavidin; conjugation to streptavidin agarose beads or streptavidin magnetic beads.

  • PA007394.r2a: In vivo Grade Recombinant Anti-mouse CD115 Monoclonal Antibody, Rat IgG2a Kappa (Clone: AFS98)

    The in vivo grade recombinant anti-mouse CD115 rat IgG2a monoclonal antibody was produced in mammalian cells. 
    Specificity/Sensitivity: The in vivo grade recombinant rat monoclonal antibody (clone: AFS98) specifically binds to mouse CD115.
    Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse CD115 protein.

  • BP003299: Biotinylated Human Peptide Ready HLA-E*01:03&B2M Monomer Protein with the C-His-Avi Tag

    Source: The recombinant Biotinylated Human Peptide Ready HLA-E*01:03&B2M Monomer Protein, (amino acids Gly25-Ile305(HLA-E*01:03) & Ile21-Met119(B2M)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity:
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP003300: Human Peptide Ready HLA-E*01:03&B2M Monomer Protein with the C-His-Avi Tag

    Source: The recombinant Human Peptide Ready HLA-E*01:03&B2M Monomer Protein, (amino acids Gly25-Ile305(HLA-E*01:03) & Ile21-Met119(B2M)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity:
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP005219: Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer Protein with the C-His-Avi Tag

    Source: The recombinant Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer Protein, (amino acids Gly25-Ile305(HLA-E*01:03), Ile21-Met119(B2M) and VMAPRTLVL peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: The affinity constant of 17.61 nM as determined in SPR assay (Biacore T200).
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP004250: Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer Protein with the C-His-Avi Tag

    Source: The recombinant Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer Protein, (amino acids Gly25-Ile305(HLA-E*01:03), Ile21-Met119(B2M) and VMAPRTLVL peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity:
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP004967: Biotinylated Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer Protein with the C-His-Avi Tag

    Source: The recombinant Biotinylated Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer Protein, (amino acids Gly25-Ile305(HLA-E*01:03), Ile21-Met119(B2M)and VMAPRTLVL peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity:
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP005220: Biotinylated Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer Protein with the C-His-Avi Tag

    Source: The recombinant Biotinylated Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer Protein, (amino acids Gly25-Ile305(HLA-E*01:03), Ile21-Met119(B2M) and VMAPRTLVL peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity:
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP000030-GD4: Recombinant Human FGF Basic

    Source: E. coli-derived.
    The FGF basic (bFGF/FGF-2/FGF2) activity is measured in a cell proliferation assay using NIH-3T3 mouse fibroblasts. The ED50 for this effect is less than 0.5 ng/ml.
    Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
    Purity: > 95% by SDS-PAGE under reducing conditions.

See our Privacy Policy